| scholarly article | Q13442814 |
| P2093 | author name string | Kenneth D Bloch | |
| Binglan Yu | |||
| Warren M Zapol | |||
| Gian Paolo Volpato | |||
| Keqin Chang | |||
| P2860 | cites work | Hb-based oxygen carriers: are we there yet? | Q28206212 |
| Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial | Q28208079 | ||
| Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis | Q28278052 | ||
| Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery | Q28344146 | ||
| Summary: systemic effects of inhaled nitric oxide | Q30439923 | ||
| Extrapulmonary effects of inhaled nitric oxide: role of reversible S-nitrosylation of erythrocytic hemoglobin | Q30440013 | ||
| Recombinant human hemoglobin with reduced nitric oxide-scavenging capacity restores effectively pancreatic microcirculatory disorders in hemorrhagic shock | Q31067760 | ||
| Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin | Q34133584 | ||
| Artificial blood: an update on current red cell and platelet substitutes. | Q34151145 | ||
| Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. | Q34612107 | ||
| Current status of blood substitute research: towards a new paradigm | Q35110088 | ||
| No scavenging and the hypertensive effect of hemoglobin-based blood substitutes | Q35678150 | ||
| Inhaled NO as a therapeutic agent | Q36003322 | ||
| Insights from studies of blood substitutes in trauma. | Q36246297 | ||
| The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics | Q37048314 | ||
| All hemoglobin-based oxygen carriers are not created equally | Q37061124 | ||
| Pulmonary intravascular macrophages | Q40660693 | ||
| A fluorometric assay for the measurement of nitrite in biological samples. | Q41526007 | ||
| Inhaled nitric oxide enables artificial blood transfusion without hypertension | Q42152657 | ||
| Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients | Q42629484 | ||
| Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin | Q43730783 | ||
| Role of redox potential of hemoglobin-based oxygen carriers on methemoglobin reduction by plasma components | Q43986348 | ||
| Effects of recombinant-hemoglobin solutions rHb2.0 and rHb1.1 on blood pressure, intestinal blood flow, and gut oxygenation in a rat model of hemorrhagic shock | Q45236903 | ||
| Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD. | Q45927570 | ||
| Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury | Q47351587 | ||
| A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified Hemoglobin (Hemospan) in patients undergoing major orthopedic surgery | Q48641410 | ||
| Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension. | Q51398065 | ||
| Inhaled Nitric Oxide A Selective Pulmonary Vasodilator of Heparin-Protamine Vasoconstriction in Sheep | Q51701572 | ||
| Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep. Evidence for the role of reactive oxygen metabolites following nonimmunological complement activation. | Q51772876 | ||
| Resuscitation with recombinant hemoglobin rHb2.0 in a rodent model of hemorrhagic shock. | Q51795653 | ||
| Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. | Q54169593 | ||
| Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure | Q73080410 | ||
| Isovolemic hemodilution with a bovine hemoglobin-based oxygen carrier: effects on hemodynamics and oxygen transport in comparison with a nonoxygen-carrying volume substitute | Q73127453 | ||
| Redox concerns in the use of acellular hemoglobin-based therapeutic oxygen carriers: the role of plasma components | Q73152047 | ||
| Resuscitation of pulmonary contusion: effects of a red cell substitute | Q73267534 | ||
| Long-term inhalation of nitric oxide for a patient with primary pulmonary hypertension | Q77798771 | ||
| Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children | Q80134666 | ||
| Effects of endogenous ascorbate on oxidation, oxygenation, and toxicokinetics of cell-free modified hemoglobin after exchange transfusion in rat and guinea pig | Q80593505 | ||
| Resuscitation from hemorrhagic shock comparing standard hemoglobin-based oxygen carrier (HBOC)-201 versus 7.5% hypertonic HBOC-201 | Q81578626 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breathing | Q9530 |
| P304 | page(s) | 113-122 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Anesthesiology | Q2012635 |
| P1476 | title | Prevention of the pulmonary vasoconstrictor effects of HBOC-201 in awake lambs by continuously breathing nitric oxide | |
| P478 | volume | 110 |
| Q36990411 | Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids. |
| Q36870257 | Cell-free hemoglobin and its scavenger proteins: new disease models leading the way to targeted therapies |
| Q52683000 | Development of a portable mini-generator to safely produce nitric oxide for the treatment of infants with pulmonary hypertension. |
| Q33692944 | Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier |
| Q36801603 | Examining and mitigating acellular hemoglobin vasoactivity |
| Q37150808 | Hemoglobin infusion does not alter murine pulmonary vascular tone |
| Q57025124 | Inhaled Nitric Oxide |
| Q46420266 | Normalization of hemoglobin-based oxygen carrier-201 induced vasoconstriction: targeting nitric oxide and endothelin |
| Q35816434 | Pulmonary hypertension after prolonged hypoxic exposure in mice with a congenital deficiency of Cyp2j |
| Q35802303 | Pulmonary hypertension in lambs transfused with stored blood is prevented by breathing nitric oxide |
| Q33803027 | Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine |
| Q34501963 | Reversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide |
| Q35783934 | Simulation of NO and O2 transport facilitated by polymerized hemoglobin solutions in an arteriole that takes into account wall shear stress-induced NO production |
| Q41873130 | Sodium nitrite therapy attenuates the hypertensive effects of HBOC-201 via nitrite reduction |
| Q39314714 | The potential adverse effects of haemolysis |
Search more.